samedan logo
 
 
spacer
home > pmps > winter 2017 > watching the east
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Watching the East

The pharmaceutical industry is one of the most competitive sectors in the EU. It is the fifth largest industrial area and accounts for a high percentage of the global pharma market. According to the European Federation of Pharmaceutical Industries and Associations, few other fields can match its contribution to generating a trade surplus, investment in R&D and the creation of skilled employment in Europe.

While a large proportion of pharmaceutical development and manufacturing takes place on the western continent, central and eastern European countries are emerging as an attractive alternative for companies wishing to outsource parts of the supply chain due to factors such as accomplished workforces and competitive pricing.

European Landscape

The pharma sector in Europe has grown exponentially over the past ten years. Businesses have had to overcome a number of challenges, like escalating costs and downward price pressure from governments coupled with the need for faster turnaround times to bring new drugs to market, as well as increased demand for products.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Anthony Sheehan joined Saneca Pharma as Chief Executive Officer in 2015. With over 25 years’ experience in the pharma industry, he has worked as Site Managing Director at Stada as well as in various senior roles within the sector. Anthony also has experience in the automotive and engineering fields. He has an MBA from the University of Limerick, Ireland.
Print this page
Send to a friend
Privacy statement
News and Press Releases

LifeArc Joins Forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to Strengthen Antimicrobial Discovery Efforts

LifeArc, a national medical research charity, is joining the Cystic Fibrosis (CF) Antimicrobial Resistance (AMR) Syndicate in a strategic partnership alongside Cystic Fibrosis Trust and Medicines Discovery Catapult (MDC).
More info >>

White Papers

Running Smarter Trials With Data-Driven Monitoring

PAREXEL

Clinical monitoring remains one of the most important and most costly activities in the clinical research paradigm.  Monitoring provides the operational transparency required by investigators, sponsors, and regulators to make informed decisions about site performance, patient safety, and overall study progress. Yet unlike many clinical trial activities, which have been steadily transformed by technology, the monitoring function itself has changed little.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement